Breast Ultrasound Market Size & Share 2026 - 2035

Breast Ultrasound Market Size

The global breast ultrasound market was valued at USD 3.5 billion in 2025 and is projected to grow from USD 3.7 billion in 2026 to USD 7.6 billion by 2035, expanding at a CAGR of 8.3%, according to the latest report published by Global Market Insights Inc. This steady growth is driven by the growing prevalence of breast cancer worldwide, rising awareness, favourable government initiatives, and technological advancements in breast ultrasound systems.

The market increased from USD 3.1 billion in 2023 to USD 3.3 billion in 2024. The growing global incidence of breast cancer is a major driver for the breast ultrasound systems market. Breast cancer is the most commonly diagnosed cancer worldwide, accounting for approximately 12.5% of all annual cancer cases. In 2022 alone, an estimated 2.3 million women were diagnosed globally, with 670,000 deaths, highlighting its significant health burden. The American Cancer Society reported over 339,000 new cases in the U.S. during the same year, making it the second leading cause of cancer-related mortality among women.
 

This rising prevalence underscores the urgent need for early detection and accurate diagnosis, fueling demand for advanced imaging technologies like breast ultrasound systems. These systems offer non-invasive, radiation-free screening, making them a preferred choice for routine examinations and follow-ups. Furthermore, projections from India’s National Cancer Registry Program indicate over 230,000 cases by 2025, reflecting a growing patient pool in emerging markets. As awareness and screening programs expand globally, healthcare providers increasingly adopt ultrasound systems to improve diagnostic accuracy and patient outcomes, thereby driving market growth.
 

Additionally, rising awareness and favorable government initiatives regarding breast cancer are key drivers for the breast ultrasound market as they significantly increase screening rates and early detection efforts. Public health campaigns and educational programs have improved knowledge about breast cancer risks, symptoms, and the importance of timely diagnosis, encouraging more women to undergo regular check-ups. This surge in awareness directly translates into higher demand for advanced imaging technologies like breast ultrasound systems, which are preferred for their non-invasive, radiation-free nature and ability to provide accurate results.
 

Governments worldwide are actively supporting these efforts through national screening programs, subsidies, and partnerships with healthcare providers to make diagnostic services more accessible and affordable. Additionally, emerging economies are investing heavily in healthcare infrastructure, creating new opportunities for manufacturers to introduce portable and AI-integrated ultrasound devices. These measures not only improve patient outcomes by enabling early intervention but also stimulate technological innovation and market penetration. In conclusion, the combination of rising awareness and proactive government policies is creating a favorable environment for breast ultrasound adoption globally, driving market growth.
 

Breast ultrasound is a non-invasive diagnostic imaging technique that uses high-frequency sound waves to produce images of the breast tissue. It is commonly used to detect abnormalities such as cysts, lumps, and tumors in the breast. The breast ultrasound market includes various products such as ultrasound systems, probes, as well as accessories.
 

Breast Ultrasound Market Trends

• Technological advancements in breast ultrasound systems are significantly driving market growth. The introduction of innovative solutions for scanning dense breast tissue and detecting small tumors at an early stage is transforming diagnostic capabilities. These advancements not only improve accuracy but also enhance patient comfort and efficiency during examinations. As healthcare providers increasingly prioritize early detection, the demand for cutting-edge ultrasound technologies continues to rise, creating strong growth potential for the industry.
   
• Leading market players in developed regions are actively launching novel technologies to strengthen their market position. For instance, in May 2022, the U.S. FDA approved the ATUSA System by iSono Health, Inc., the world’s first automated and wearable 3D breast ultrasound device. This breakthrough technology offers point-of-care imaging, improved diagnostic precision, and a more comfortable experience for patients. Such innovations are expected to accelerate adoption and expand the market footprint globally.
   
• Companies are also focusing on strategic initiatives such as government approvals, acquisitions, and new product launches to enhance their customer base. A notable example is GE Healthcare’s FDA-approved Invenia ABUS 2.0, designed to improve cancer detection in women with dense breast tissue. This system addresses limitations of traditional mammography by offering advanced imaging capabilities that reduce delays in diagnosis. These product innovations highlight the industry’s commitment to improving diagnostic accuracy and patient outcomes, which will further stimulate market growth.
   
• Automated breast ultrasound technology is gaining widespread acceptance due to its unique benefits, including three-dimensional imaging, radiation-free operation, and non-invasive procedures. These systems offer fast turnaround times, high diagnostic accuracy, and affordability, while requiring minimal operator intervention. Continuous technological breakthroughs in automation and AI integration are expected to enhance these advantages, making breast ultrasound a preferred choice for screening and diagnosis. Collectively, these developments position the market for robust expansion throughout the forecast period.
   

Breast Ultrasound Market Analysis

Based on type, the market is segmented into conventional ultrasound, and automated ultrasound. The automated ultrasound segment was valued at USD 2.3 billion in 2025 and held a significant market share of 65.1%.
 

• Automated Breast Ultrasound systems (ABUS) is an advanced imaging technology designed to overcome limitations of conventional ultrasound, particularly in women with dense breast tissue. Unlike traditional handheld systems, ABUS uses automated scanning to capture comprehensive, high-resolution 3D images of the entire breast. This technology minimizes operator dependency, ensures consistent image quality, and provides a more standardized approach to breast cancer screening and diagnosis. Its ability to deliver detailed visualization makes ABUS a preferred choice for early detection and accurate assessment.
   
• Dense breast tissue often reduces the effectiveness of mammography systems, creating a need for alternative imaging solutions. ABUS addresses this challenge by offering superior imaging capabilities, improving cancer detection rates, and reducing false negatives. Additionally, its automated nature enhances workflow efficiency, reduces examination time, and minimizes human error, making it highly attractive for hospitals and diagnostic centers. These benefits, combined with rising awareness and screening programs, are fueling demand for ABUS globally.
   
• Several leading companies are introducing innovative ABUS systems to strengthen their market presence. For instance, GE Healthcare launched Invenia ABUS 2.0, an FDA-approved device specifically designed for screening women with dense breasts. This system provides 3D imaging and advanced visualization tools to improve diagnostic accuracy.
   
• In conclusion, the automated breast ultrasound segment dominates the market due to its ability to deliver accurate, standardized, and efficient imaging solutions. With increasing breast cancer prevalence, growing awareness, and technological advancements, ABUS is becoming an essential tool for early detection and improved patient outcomes.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the breast ultrasound market is bifurcated into hospitals, diagnostic laboratories, and other end users. The hospitals segment held a significant market share of 45.6% in 2024.
 

• Hospitals remain the primary point of care for patients undergoing breast cancer screening and diagnosis, as they offer comprehensive imaging capabilities and access to advanced breast ultrasound technologies. These facilities are equipped with conventional and automated breast ultrasound systems, enabling accurate detection of abnormalities, especially in women with dense breast tissue. Their ability to provide complete diagnostic services, including follow-up imaging and biopsy procedures, makes them the most preferred setting for breast cancer evaluation.
   
• The dominance of this segment is supported by the availability of skilled radiologists, specialized breast imaging units, and integration of high-end diagnostic systems such as AI-powered ultrasound platforms. Hospitals also serve as hubs for early detection programs and preventive care initiatives, ensuring timely diagnosis and reducing the risk of late-stage cancer. The presence of advanced imaging infrastructure and trained personnel enhances diagnostic accuracy and patient confidence, driving the adoption of breast ultrasound systems in these settings.
   
• Growing integration of AI and cloud-based imaging platforms within hospital networks is further enhancing diagnostic efficiency and accessibility. Hospitals are increasingly adopting AI-powered breast ultrasound systems that enable automated lesion detection, risk assessment, and standardized reporting, reducing interpretation errors and improving workflow. Cloud connectivity allows secure storage and sharing of imaging data for remote consultations and second opinions, ensuring timely diagnosis for patients in underserved regions. These advancements not only improve clinical outcomes but also strengthen the role of hospitals as key hubs for advanced breast imaging services.
   
• As breast cancer prevalence continues to rise globally, hospitals and clinics will play a pivotal role in breast imaging and diagnosis. Investments in advanced ultrasound technologies, telehealth infrastructure, and integrated care models will strengthen their position as the leading end-user segment
   

North America Breast Ultrasound Market

The North America region accounted for 34% of the global market in 2025. The market in North America is experiencing robust expansion, driven by the region’s advanced healthcare infrastructure and technological advancements.
 

• The U.S. market was valued at USD 819.8 million and USD 945.3 million in 2022 and 2023, respectively. In 2025, the market size reached USD 1,081.1 million from USD 1,009.7 million in 2024. U.S. dominates the breast ultrasound market in North America, primarily driven by increasing prevalence of breast cancer is a major driver for the U.S. market, as it significantly boosts the need for advanced diagnostic solutions. According to the data shown in the image, an estimated 316,950 new cases of female breast cancer are expected in 2025, accounting for 15.5% of all new cancer cases. Additionally, breast cancer is projected to cause 42,170 deaths, representing 6.8% of all cancer-related deaths. These alarming statistics highlight the growing burden of breast cancer in the U.S., emphasizing the importance of early detection and accurate diagnosis.
   
• This rising incidence directly fuels the demand for breast ultrasound systems, which are widely used for screening and diagnostic purposes. Ultrasound is particularly effective for women with dense breast tissue, where mammography may have limitations.
   
• Technology’s non-invasive nature, absence of radiation, and ability to provide real-time imaging make it a preferred choice for clinicians and patients alike. As the number of cases continues to climb, healthcare providers are increasingly adopting advanced ultrasound systems, including automated and AI-powered solutions, to improve detection rates and reduce diagnostic errors.
   
• In conclusion, the growing prevalence of breast cancer in the U.S. creates a strong need for reliable imaging technologies, positioning breast ultrasound as a critical tool in cancer management.
   

Europe Breast Ultrasound Market

Europe market accounted for USD 910.6 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• The rising incidence of breast cancer across Europe is a major factor driving the growth of the market. Breast cancer screening and early detection have become critical healthcare priorities, leading to increased adoption of advanced imaging modalities. Ultrasound is widely recognized as a complementary tool to mammography, particularly for dense breast tissue, offering non-invasive, radiation-free diagnostics. As awareness campaigns and government initiatives emphasize early detection, healthcare providers are investing in ultrasound systems to improve diagnostic accuracy and patient outcomes.
   
• According to Europa Donna, breast cancer is the most common cancer in women in the WHO Europe region, with an estimated 604,900 new cases in 2022. This alarming prevalence underscores the urgent need for reliable and accessible diagnostic solutions. Breast ultrasound plays a vital role in confirming suspicious findings from mammograms and guiding biopsies, making it indispensable in comprehensive breast cancer care. The growing patient pool and emphasis on personalized treatment pathways are accelerating demand for advanced ultrasound technologies, including automated breast ultrasound systems (ABUS) and portable devices.
   
• The increasing burden of breast cancer in Europe is directly stimulating the expansion of the market. As healthcare systems prioritize early detection and accurate diagnosis, ultrasound technology is positioned as a cost-effective, safe, and efficient solution.
   

Germany's breast ultrasound market is projected to experience steady growth between 2026 and 2035.
 

• Technological innovation is a key driver shaping the breast ultrasound market in Germany. Advanced imaging solutions, such as automated breast ultrasound systems (ABUS), 3D/4D imaging, and AI-powered diagnostic tools, are transforming breast cancer screening and diagnosis.
   
• These innovations enhance image clarity, reduce operator dependency, and improve detection rates, particularly in women with dense breast tissue. German healthcare providers are increasingly adopting these systems to ensure accurate, efficient, and patient-friendly diagnostic workflows.
   

Asia Pacific Breast Ultrasound Market

The Asia Pacific region is projected to show a lucrative growth of about 8.3% during the forecast period.
 

• The Asia-Pacific region is witnessing a significant rise in breast cancer cases, which is a primary factor driving the demand for breast ultrasound systems. Increasing urbanization, lifestyle changes, and delayed childbearing have contributed to higher breast cancer incidence rates across countries such as China, India, Japan, and South Korea. As governments and healthcare organizations emphasize early detection and screening programs, breast ultrasound is gaining traction as a safe, cost-effective, and radiation-free diagnostic tool, complementing mammography and improving diagnostic accuracy.
   
• In conclusion, the rising burden of breast cancer in Asia-Pacific is a key driver accelerating the growth of the breast ultrasound market. With healthcare systems focusing on early detection and personalized care, the adoption of advanced ultrasound technologies is expected to surge. This trend will not only enhance diagnostic capabilities but also contribute to reducing mortality rates and improving quality of life for patients across the region.
   

Japan breast ultrasound market is poised to witness lucrative growth between 2026 – 2035.
 

• Increasing awareness about breast cancer among women in Japan, coupled with proactive government initiatives, is significantly driving the growth of the market. Public health campaigns, educational programs, and community outreach efforts have improved knowledge about early detection and screening. These initiatives encourage women to undergo regular check-ups, creating higher demand for diagnostic imaging solutions such as breast ultrasound, which is widely recognized for its safety and effectiveness in detecting abnormalities.
   
• The Japanese government has implemented several policies to promote breast cancer screening, including subsidized programs and partnerships with healthcare providers. These measures aim to reduce mortality rates by ensuring timely diagnosis and treatment.
   
• Rising awareness and strong government backing for breast cancer screening in Japan are key drivers stimulating the market. As healthcare authorities continue to prioritize early detection and improve accessibility to advanced imaging technologies, the market is expected to witness growth.
   

Latin America Breast Ultrasound Market

Brazil is experiencing significant growth in the breast ultrasound industry.
 

• The rising incidence of breast cancer across Latin America is a major factor driving the demand for breast ultrasound systems. Countries such as Brazil, Mexico, and Argentina are witnessing an increase in breast cancer cases due to changing lifestyles, urbanization, and limited access to early screening in rural areas. This growing burden has prompted healthcare providers and governments to prioritize early detection, creating strong demand for cost-effective and radiation-free diagnostic tools like breast ultrasound, which improves diagnostic accuracy.
   
• Additionally, as breast cancer becomes one of the leading causes of mortality among women in the region, healthcare systems are investing in advanced imaging technologies to improve outcomes. Breast ultrasound systems, including automated breast ultrasound (ABUS) and portable devices, are gaining traction in hospitals and diagnostic centers to address the need for timely and accurate diagnosis. This trend is further supported by awareness campaigns and initiatives aimed at expanding screening coverage, which is expected to accelerate market growth in the coming years.
   
• As a result, the growing prevalence of breast cancer in Latin America is a key driver boosting the breast ultrasound market. With increasing emphasis on early detection and improved accessibility to advanced imaging solutions, the market is poised for significant expansion, ultimately contributing to better patient care and reduced mortality rates across the region.
   

Middle East and Africa Breast Ultrasound Market

• Breast cancer is the most commonly diagnosed cancer among women in Saudi Arabia, and its prevalence has been steadily increasing over the past decade. Factors such as changing lifestyles, obesity, and delayed pregnancies have contributed to this rise, creating an urgent need for early detection and accurate diagnosis.
   
• Breast ultrasound has emerged as a preferred imaging modality due to its non-invasive nature, absence of radiation, and cost-effectiveness compared to other diagnostic techniques. As awareness campaigns and government initiatives promote regular screening, healthcare facilities are investing in advanced ultrasound systems to meet the growing demand.
   
• The escalating burden of breast cancer in Saudi Arabia is a critical driver for the market. With a strong focus on early diagnosis and improved patient outcomes, the adoption of innovative ultrasound technologies is expected to accelerate, positioning the market for significant growth in the coming years.
   

Breast Ultrasound Market Share

• The top players in the market include Samsung Electronics Co. Ltd., GE Healthcare, Canon Medical Systems Corporation, Koninklijke Philips N.V., and Siemens Healthineers AG, collectively accounting for 70% share of the global market. Leading companies are driving innovation to enhance breast cancer screening and diagnosis worldwide.
   
• They are investing in AI-powered ultrasound platforms, portable imaging devices, and automated breast scanning technologies to enable faster, more accurate detection. These advancements help improve diagnostic confidence, reduce the need for invasive procedures, and support early intervention, ultimately improving patient outcomes and lowering healthcare costs.
   
• Through acquisitions and global expansion strategies, these companies are strengthening their position in the breast ultrasound ecosystem. Partnerships with hospitals, diagnostic imaging centers, and telemedicine platforms enabling broader access to advanced ultrasound technologies, particularly in emerging markets. This collaborative approach ensures timely screening, better continuity of care, and improved accessibility for underserved populations.
   
• In conclusion, the focus on automation, real-time imaging, and regulatory compliance by these industry leaders will significantly shape the future of the breast ultrasound market.
   
• Their commitment to innovation and strategic alliances will accelerate adoption globally, improve patient outcomes, and drive sustained market growth.
   

Breast Ultrasound Market Companies

Few of the prominent players operating in the breast ultrasound industry include:

• CapeRay
• Delphinus Medical Technologies, Inc.
• GE Healthcare
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Canon Medical Systems Corporation
• Fukuda Denshi
• Hologic, Inc.
• Seno Medical Instruments Inc.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Samsung Electronics Co. Ltd.
• FujiFilm Holdings Corporation
   
• Koninklijke Philips N.V.

Koninklijke Philips N.V. is a major innovator in healthcare technology, offering breast ultrasound solutions that combine superior imaging quality with intuitive user interfaces. Philips focuses on enhancing early detection and personalized care through AI-enabled imaging and telehealth integration. Its strong global presence and dedication to clinical education position Philips as a key partner in advancing breast cancer screening and diagnosis.
 

• Siemens Healthineers AG

Siemens Healthineers AG is a leading provider of medical imaging solutions, delivering breast ultrasound systems that incorporate advanced imaging algorithms and workflow optimization tools. The company emphasizes precision diagnostics and digitalization, enabling clinicians to achieve faster and more accurate results. Siemens Healthineers’ strategic investments in AI and cloud-based platforms reinforce its leadership in breast imaging and comprehensive cancer care.
 

• FujiFilm Holdings Corporation

FujiFilm Holdings Corporation is a leader in advanced diagnostic imaging, providing breast ultrasound solutions through its ARIETTA DeepInsight series that combine proprietary AI-driven image processing with exceptional ergonomic design. FujiFilm focuses on transforming diagnostic workflows through DeepInsight technology, utilizing advanced deep learning algorithms to achieve superior image reproducibility, accuracy, and visibility while minimizing operator dependency. Its comprehensive ecosystem - spanning the portable Sonosite POCUS systems to premium ARIETTA platforms - and strong commitment to seamless workflow integration position FujiFilm as a trusted innovator in accelerating breast cancer detection and advancing diagnostic confidence worldwide.
 

Breast Ultrasound Market News:

• In October 2021, Delphinus Medical Technologies, Inc. received premarket approval for its SoftVue 3D whole breast ultrasound imaging system by U.S. FDA for screening breast cancer among asymptomatic women with dense breasts. This has offered lucrative growth opportunities to the firm. 
   
• In September 2021, GE Healthcare entered into an agreement to acquire BK Medical, a surgical visualization company. This acquisition boosted the company’s precision health presence with the help of ultrasound systems.
   

The breast ultrasound market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Conventional ultrasound
• Automated ultrasound       

Market, By End Use

• Hospitals
• Diagnostic Laboratories
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE